I-ying C. Kuo

Kaohsiung, KHQ 80708, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Increasing autophagy activity suppresses Helicobacter pylori infection-related gastric cancer tumorigenesis both in vitro and in vivo.

Increasing autophagy activity suppresses Helicobacter pylori infection-related gastric cancer tumorigenesis both in vitro and in vivo.

Journal: American journal of cancer research

Published: November 16, 2025

Rab37-mediated OPN secretion enriches SPP1+ macrophages through autocrine-paracrine signaling to drive lung tumor progression.

Rab37-mediated OPN secretion enriches SPP1+ macrophages through autocrine-paracrine signaling to drive lung tumor progression.

Journal: Oncogenesis

Published: September 27, 2025

Effect of Oseltamivir Use on Follow-Up Stroke Mortality.

Effect of Oseltamivir Use on Follow-Up Stroke Mortality.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 21, 2025

Deubiquitinating enzymes: Key regulators of ferroptosis and pyroptosis and novel targets for cancer intervention.

Deubiquitinating enzymes: Key regulators of ferroptosis and pyroptosis and novel targets for cancer intervention.

Journal: International journal of biological sciences

Published: February 10, 2025

Impact of Oseltamivir and Diabetes Development.

Impact of Oseltamivir and Diabetes Development.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 29, 2024

Correction: PTPN23 ubiquitination by WDR4 suppresses EGFR and c-MET degradation to define a lung cancer therapeutic target.

Correction: PTPN23 ubiquitination by WDR4 suppresses EGFR and c-MET degradation to define a lung cancer therapeutic target.

Journal: Cell death & disease

Published: July 02, 2024

Fully human chitinase-3 like-1 monoclonal antibody inhibits tumor growth, fibrosis, angiogenesis, and immune cell remodeling in lung, pancreatic, and colorectal cancers.

Fully human chitinase-3 like-1 monoclonal antibody inhibits tumor growth, fibrosis, angiogenesis, and immune cell remodeling in lung, pancreatic, and colorectal cancers.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 29, 2024

Revealing potential Rab proteins participate in regulation of secretory autophagy machinery.

Revealing potential Rab proteins participate in regulation of secretory autophagy machinery.

Journal: The Kaohsiung journal of medical sciences

Published: March 11, 2024

Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion.

Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion.

Journal: Cell communication and signaling : CCS

Published: February 26, 2024

Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer.

Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer.

Journal: Journal of biomedical science

Published: July 13, 2023

PTPN23 ubiquitination by WDR4 suppresses EGFR and c-MET degradation to define a lung cancer therapeutic target.

PTPN23 ubiquitination by WDR4 suppresses EGFR and c-MET degradation to define a lung cancer therapeutic target.

Journal: Cell death & disease

Published: April 05, 2023

Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.

Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.

Journal: Journal of biomedical science

Published: July 15, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026